Aseptic Processing for Cytotherapy, Regenerative Medicine, and Tissue-Engineered Products

Author(s)Mamoru Kokubo, James E. Akers

Isolators offer a safety and economic advantage for next-generation regenerative medicine products.

BioPharm International

eBooks Volume 28, Issue 14

Manufacturing advanced biologics demands solutions that are quite different from what is being used for large-scale industrial biologics processing today. This article touches on approaches that work with advanced biologics. Read this article and other articles in

BioPharm International

's 2015

The Future of Bioprocessing

eBook.

Articles in this issue

over 10 years ago

Article

Fluctuating Capacity and Demand Conditions in Biomanufacturing

over 10 years ago

Article

Cleaning Validation for Biologics

over 10 years ago

Article

Automation of Single-Use Systems

over 10 years ago

Article

Are Biopharma Patents Poised on the Post-Grant Chopping Block?

over 10 years ago

Article

Innovations in Automation—High-Throughput Dynamic Light Scattering for Screening Biotherapeutic Formulations

over 10 years ago

Article

Raising the Bar for Biopharma Training

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!